Protein 4.1 and the control of ion channels

Blood Cells, Molecules, and Diseases

Volumn 42, Issue 3, 2009, Pages 211-215

  Baines, Anthony J ^a   Bennett, Pauline M ^b   Carter, Edward W ^a   Terracciano, Cesare ^c  

^a UNIVERSITY OF KENT   (United Kingdom)

^b KING'S COLLEGE LONDON   (United Kingdom)

^c NATIONAL HEART AND LUNG INSTITUTE   (United Kingdom)

Author keywords

Cardiomyocyte; Cytoskeleton; Erythrocyte; Heart rate; Sodium channels

Indexed keywords

ACTIN; ANKYRIN; ERYTHROCYTE BAND 4.1 PROTEIN; GLUTAMATE RECEPTOR 1; GLUTAMATE RECEPTOR 4; PROTEIN 4.1R; SPECTRIN; TRANSIENT RECEPTOR POTENTIAL CHANNEL 4; UNCLASSIFIED DRUG; VOLTAGE GATED SODIUM CHANNEL;

ACTION POTENTIAL; BRADYCARDIA; CELL SURFACE; CHANNEL GATING; ERYTHROCYTE MEMBRANE; HEART; IMMUNOREACTIVITY; KNOCKOUT MOUSE; NERVE CELL; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN FUNCTION; QT PROLONGATION; REVIEW;

ANIMALS; ARRHYTHMIAS, CARDIAC; BLOOD PROTEINS; BRADYCARDIA; CYTOSKELETAL PROTEINS; ELLIPTOCYTOSIS, HEREDITARY; EPITHELIAL CELLS; ERYTHROCYTES; HEART; HUMANS; ION CHANNELS; LONG QT SYNDROME; MEMBRANE PROTEINS; MICE; MULTIGENE FAMILY; MYOCARDIUM; MYOCYTES, CARDIAC; NEURONS; PROTEIN STRUCTURE, TERTIARY; SODIUM CHANNELS;

MAMMALIA; MUS;

EID: 64649087024     PISSN: 10799796     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bcmd.2009.01.016     Document Type: Review

References (56)

1. Gallagher P.G. Hereditary elliptocytosis: spectrin and protein 4.1R. Semin. Hematol. 41 (2004) 142-164
2. Tyler J.M., Hargreaves W.R., and Branton D. Purification of two spectrin-binding proteins: biochemical and electron microscopic evidence for site-specific reassociation between spectrin and bands 2.1 and 4.1. Proc. Natl. Acad. Sci. U. S. A. 76 (1979) 5192-5196
3. Ungewickell E., Bennett P.M., Calvert R., Ohanian V., and Gratzer W.B. In vitro formation of a complex between cytoskeletal proteins of the human erythrocyte. Nature 280 (1979) 811-814
4. Discher D., Parra M., Conboy J.G., and Mohandas N. Mechanochemistry of the alternatively spliced spectrin-actin binding domain in membrane skeletal protein 4.1. J. Biol. Chem. 268 (1993) 7186-7195
5. Cohen A.M., Liu S.C., Lawler J., Derick L., and Palek J. Identification of the protein 4.1 binding site to phosphatidylserine vesicles. Biochemistry 27 (1988) 614-619
6. An X.L., Takakuwa Y., Manno S., Han B.G., Gascard P., and Mohandas N. Structural and functional characterization of protein 4.1R-phosphatidylserine interaction: potential role in 4.1R sorting within cells. J. Biol. Chem. 276 (2001) 35778-35785
7. An X., Zhang X., Debnath G., Baines A.J., and Mohandas N. Phosphatidylinositol-4,5-biphosphate (PIP2) differentially regulates the interaction of human erythrocyte protein 4.1 (4.1R) with membrane proteins. Biochemistry 45 (2006) 5725-5732
8. Pasternack G.R., Anderson R.A., Leto T.L., and Marchesi V.T. Interactions between protein 4.1 and band 3. An alternative binding site for an element of the membrane skeleton. J. Biol. Chem. 260 (1985) 3676-3683
9. Alloisio N., Dalla Venezia N., Rana A., Andrabi K., Texier P., Gilsanz F., Cartron J.P., Delaunay J., and Chishti A.H. Evidence that red blood cell protein p55 may participate in the skeleton-membrane linkage that involves protein 4.1 and glycophorin C. Blood 82 (1993) 1323-1327
10. Gascard P., and Cohen C.M. Absence of high-affinity band 4.1 binding sites from membranes of glycophorin C- and D-deficient (Leach phenotype) erythrocytes. Blood 83 (1994) 1102-1108
11. Pinder J.C., Chung A., Reid M.E., and Gratzer W.B. Membrane attachment sites for the membrane cytoskeletal protein 4.1 of the red blood cell. Blood 82 (1993) 3482-3488
12. Reid M.E., Takakuwa Y., Conboy J., Tchernia G., and Mohandas N. Glycophorin C content of human erythrocyte membrane is regulated by protein 4.1. Blood 75 (1990) 2229-2234
13. Leto T.L., and Marchesi V.T. A structural model of human-erythrocyte protein-4.1. J. Biol. Chem. 259 (1984) 4603-4608
14. Han B.G., Nunomura W., Takakuwa Y., Mohandas N., and Jap B.K. Protein 4.1R core domain structure and insights into regulation of cytoskeletal organization. Nat. Struct. Biol. 7 (2000) 871-875
15. Manno S., Takakuwa Y., and Mohandas N. Modulation of erythrocyte membrane mechanical function by protein 4.1 phosphorylation. J. Biol. Chem. 280 (2005) 7581-7587
16. Conboy J. The role of alternative pre-mRNA splicing in regulating the structure and function of skeletal protein 4.1. Proc. Soc. Exp. Biol. Med. 220 (1999) 73-78
17. Nunomura W., and Takakuwa Y. Regulation of protein 4.1R interactions with membrane proteins by Ca2+ and calmodulin. Front. Biosci. 11 (2006) 1522-1539
18. Salomao M., Zhang X., Yang Y., Lee S., Hartwig J.H., Chasis J.A., Mohandas N., and An X. Protein 4.1R-dependent multiprotein complex: new insights into the structural organization of the red blood cell membrane. Proc. Natl. Acad. Sci. U. S. A. 105 (2008) 8026-8031
19. Bennett V., and Baines A.J. Spectrin and ankyrin-based pathways: metazoan inventions for integrating cells into tissues. Physiol. Rev. 81 (2001) 1353-1392
20. Kasahara M. The 2R hypothesis: an update. Curr. Opin. Immunol. 19 (2007) 547-552
21. Taylor-Harris P.M., Felkin L.E., Birks E.J., Franklin R.C., Yacoub M.H., Baines A.J., Barton P.J., and Pinder J.C. Expression of human membrane skeleton protein genes for protein 4.1 and betaIISigma2-spectrin assayed by real-time RT-PCR. Cell. Mol. Biol. Lett. 10 (2005) 135-149
22. Taylor-Harris P.M., Keating L.A., Maggs A.M., Phillips G.W., Birks E.J., Franklin R.C., Yacoub M.H., Baines A.J., and Pinder J.C. Cardiac muscle cell cytoskeletal protein 4.1: analysis of transcripts and subcellular location-relevance to membrane integrity, microstructure, and possible role in heart failure. Mamm. Genome 16 (2005) 137-151
23. Stagg M.A., Carter E., Sohrabi N., Siedlecka U., Soppa G.K., Mead F., Mohandas N., Taylor-Harris P., Baines A., Bennett P., Yacoub M.H., Pinder J.C., and Terracciano C.M.N. Cytoskeletal Protein 4.1R affects repolarization and regulates calcium handling in the heart. Circ. Res. 103 (2008) 855-863
24. Shi Z.T., Afzal V., Coller B., Patel D., Chasis J.A., Parra M., Lee G., Paszty C., Stevens M., Walensky L., Peters L.L., Mohandas N., Rubin E., and Conboy J.G. Protein 4.1R-deficient mice are viable but have erythroid membrane skeleton abnormalities. J. Clin. Invest. 103 (1999) 331-340
25. Walensky L.D., Shi Z.T., Blackshaw S., DeVries A.C., Demas G.E., Gascard P., Nelson R.J., Conboy J.G., Rubin E.M., Snyder S.H., and Mohandas N. Neurobehavioral deficits in mice lacking the erythrocyte membrane cytoskeletal protein 4.1. Curr. Biol. 8 (1998) 1269-1272
26. Luque C.M., Lallena M.J., Alonso M.A., and Correas I. An alternative domain determines nuclear localization in multifunctional protein 4.1. J. Biol. Chem. 273 (1998) 11643-11649
27. Gascard P., Lee G., Coulombel L., Auffray I., Lum M., Parra M., Conboy J.G., Mohandas N., and Chasis J.A. Characterization of multiple isoforms of protein 4.1R expressed during erythroid terminal differentiation. Blood 92 (1998) 4404-4414
28. Hayes N.V., Scott C., Heerkens E., Ohanian V., Maggs A.M., Pinder J.C., Kordeli E., and Baines A.J. Identification of a novel C-terminal variant of beta II spectrin: two isoforms of beta II spectrin have distinct intracellular locations and activities. J. Cell. Sci. 113 (2000) 2023-2034
29. Bennett P.M., Baines A.J., Lecomte M.C., Maggs A.M., and Pinder J.C. Not just a plasma membrane protein: in cardiac muscle cells alpha-II spectrin also shows a close association with myofibrils. J. Muscle Res. Cell Motil. 25 (2004) 119-126
30. Mohler P.J., and Bennett V. Ankyrin-based cardiac arrhythmias: a new class of channelopathies due to loss of cellular targeting. Curr. Opin. Cardiol. 20 (2005) 189-193
31. Mohler P.J., Rivolta I., Napolitano C., LeMaillet G., Lambert S., Priori S.G., and Bennett V. Nav1.5 E1053K mutation causing Brugada syndrome blocks binding to ankyrin-G and expression of Nav1.5 on the surface of cardiomyocytes. Proc. Natl. Acad. Sci. U. S. A. 101 (2004) 17533-17538
32. Cioffi D.L., Wu S., Alexeyev M., Goodman S.R., Zhu M.X., and Stevens T. Activation of the endothelial store-operated ISOC Ca2+ channel requires interaction of protein 4.1 with TRPC4. Circ. Res. 97 (2005) 1164-1172
33. Shen L., Liang F., Walensky L.D., and Huganir R.L. Regulation of AMPA receptor GluR1 subunit surface expression by a 4. 1N-linked actin cytoskeletal association. J. Neurosci. 20 (2000) 7932-7940
34. Coleman S.K., Cai C., Mottershead D.G., Haapalahti J.P., and Keinanen K. Surface expression of GluR-D AMPA receptor is dependent on an interaction between its C-terminal domain and a 4.1 protein. J. Neurosci. 23 (2003) 798-806
35. Bruce L.J., Beckmann R., Ribeiro M.L., Peters L.L., Chasis J.A., Delaunay J., Mohandas N., Anstee D.J., and Tanner M.J. A band 3-based macrocomplex of integral and peripheral proteins in the RBC membrane. Blood 101 (2003) 4180-4188
36. Salomao M., An X., Guo X., Gratzer W.B., Mohandas N., and Baines A.J. Mammalian alphaI-spectrin is a neofunctionalized polypeptide adapted to small highly deformable erythrocytes. Proc. Natl. Acad. Sci. U. S. A. 103 (2006) 643-648
37. Nunomura W., Takakuwa Y., Tokimitsu R., Krauss S.W., Kawashima M., and Mohandas N. Regulation of CD44-protein 4.1 interaction by Ca2+ and calmodulin. Implications for modulation of CD44-ankyrin interaction. J. Biol. Chem. 272 (1997) 30322-30328
38. Lokeshwar V.B., Fregien N., and Bourguignon L.Y. Ankyrin-binding domain of CD44(GP85) is required for the expression of hyaluronic acid-mediated adhesion function. J. Cell Biol. 126 (1994) 1099-1109
39. Pasini E.M., Kirkegaard M., Mortensen P., Lutz H.U., Thomas A.W., and Mann M. In-depth analysis of the membrane and cytosolic proteome of red blood cells. Blood 108 (2006) 791-801
40. Bourguignon L.Y., Jin H., Iida N., Brandt N.R., and Zhang S.H. The involvement of ankyrin in the regulation of inositol 1,4,5-trisphosphate receptor-mediated internal Ca2+ release from Ca2+ storage vesicles in mouse T-lymphoma cells. J. Biol. Chem. 268 (1993) 7290-7297
41. Mohler P.J., Davis J.Q., Davis L.H., Hoffman J.A., Michaely P., and Bennett V. Inositol 1,4,5-trisphosphate receptor localization and stability in neonatal cardiomyocytes requires interaction with ankyrin-B. J. Biol. Chem. 279 (2004) 12980-12987
42. Maximov A., Tang T.S., and Bezprozvanny I. Association of the type 1 inositol (1,4,5)-trisphosphate receptor with 4.1N protein in neurons. Mol. Cell. Neurosci. 22 (2003) 271-283
43. Binda A.V., Kabbani N., Lin R., and Levenson R. D2 and D3 dopamine receptor cell surface localization mediated by interaction with protein 4.1N. Mol. Pharmacol. 62 (2002) 507-513
44. Lu D., Yan H., Othman T., and Rivkees S.A. Cytoskeletal protein 4.1G is a binding partner of the metabotropic glutamate receptor subtype 1alpha. J. Neurosci. Res. 78 (2004) 49-55
45. Lu D., Yan H., Othman T., Turner C.P., Woolf T., and Rivkees S.A. Cytoskeletal protein 4.1G binds to the third intracellular loop of the A1 adenosine receptor and inhibits receptor action. Biochem. J. 377 (2004) 51-59
46. Bennett V., and Stenbuck P.J. The membrane attachment protein for spectrin is associated with band 3 in human erythrocyte membranes. Nature 280 (1979) 468-473
47. Nicolas V., Le Van Kim C., Gane P., Birkenmeier C., Cartron J.P., Colin Y., and Mouro-Chanteloup I. Rh-RhAG/ankyrin-R, a new interaction site between the membrane bilayer and the red cell skeleton, is impaired by Rh(null)-associated mutation. J. Biol. Chem. 278 (2003) 25526-25533
48. Lopez C., Metral S., Eladari D., Drevensek S., Gane P., Chambrey R., Bennett V., Cartron J.P., Le Van Kim C., and Colin Y. The ammonium transporter RhBG: requirement of a tyrosine-based signal and ankyrin-G for basolateral targeting and membrane anchorage in polarized kidney epithelial cells. J. Biol. Chem. 280 (2005) 8221-8228
49. Mohler P.J., Schott J.J., Gramolini A.O., Dilly K.W., Guatimosim S., duBell W.H., Song L.S., Haurogne K., Kyndt F., Ali M.E., Rogers T.B., Lederer W.J., Escande D., Le Marec H., and Bennett V. Ankyrin-B mutation causes type 4 long-QT cardiac arrhythmia and sudden cardiac death. Nature 421 (2003) 634-639
50. Bourguignon L.Y., Lokeshwar V.B., He J., Chen X., and Bourguignon G.J. A CD44-like endothelial cell transmembrane glycoprotein (GP116) interacts with extracellular matrix and ankyrin. Mol. Cell. Biol. 12 (1992) 4464-4471
51. Denisenko-Nehrbass N., Oguievetskaia K., Goutebroze L., Galvez T., Yamakawa H., Ohara O., Carnaud M., and Girault J.A. Protein 4.1B associates with both Caspr/paranodin and Caspr2 at paranodes and juxtaparanodes of myelinated fibres. Eur. J. Neurosci. 17 (2003) 411-416
52. Davis J.Q., and Bennett V. Ankyrin binding activity shared by the neurofascin/L1/NrCAM family of nervous system cell adhesion molecules. J. Biol. Chem. 269 (1994) 27163-27166
53. Baines A.J. A FERM-adjacent (FA) region defines a subset of the 4.1 superfamily and is a potential regulator of FERM domain function. BMC Genomics 7 (2006) 85
54. Correas I., Leto T.L., Speicher D.W., and Marchesi V.T. Identification of the functional site of erythrocyte protein 4.1 involved in spectrin-actin associations. J. Biol. Chem. 261 (1986) 3310-3315
55. Kontrogianni-Konstantopoulos A., Huang S.C., and Benz Jr. E.J. A nonerythroid isoform of protein 4.1R interacts with components of the contractile apparatus in skeletal myofibers. Mol. Biol. Cell 11 (2000) 3805-3817
56. Scott C., Phillips G.W., and Baines A.J. Properties of the C-terminal domain of 4.1 proteins. Eur. J. Biochem. 268 (2001) 3709-3717